Current Diabetes Reports

, Volume 5, Issue 2, pp 149–156 | Cite as

The role of HNF4A variants in the risk of type 2 diabetes

  • Karen L. Mohlke
  • Michael Boehnke
Article

Abstract

Genes influence susceptibility to type 2 diabetes mellitus (T2DM), and both positional cloning and candidate gene approaches have been used to identify these genes. Linkage analysis has generated evidence for T2DM-predisposing variants on chromosome 20q in studies of Caucasians, Asians, and Africans, and fine-mapping recently identified a likely susceptibility gene, hepatocyte nuclear factor 4-α (HNF4A). Rare loss-of-function mutations in HNF4A cause maturityonset diabetes of the young and now common noncoding variants have been found to be associated with T2DM.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    McCarthy MI: Growing evidence for diabetes susceptibility genes from genome scan data. Curr Diab Rep 2003, 3:159–167. A recent review of 20 T2DM genome scans, highlighting regions of interest on chromosomes 1q, 2q, 3q, 8p, 12q, and 20q, with a particular emphasis on 1q.PubMedGoogle Scholar
  2. 2.
    Hanson RL, Knowler WC: Quantitative trait linkage studies of diabetes-related traits. Curr Diab Rep 2003, 3:176–183.PubMedGoogle Scholar
  3. 3.
    Horikawa Y, Oda N, Cox NJ, et al.: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000, 26:163–175.PubMedCrossRefGoogle Scholar
  4. 4.
    Weedon MN, Schwarz PE, Horikawa Y, et al.: Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 2003, 73:1208–1212.PubMedCrossRefGoogle Scholar
  5. 5.
    Song Y, Niu T, Manson JE, et al.: Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 2004, 74:208–222.PubMedCrossRefGoogle Scholar
  6. 6.
    Florez JC, Hirschhorn J, Altshuler D: The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet 2003, 4:257–291.PubMedCrossRefGoogle Scholar
  7. 7.
    Hani EH, Boutin P, Durand E, et al.: Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998, 41:1511–1515.PubMedCrossRefGoogle Scholar
  8. 8.
    Gloyn AL, Weedon MN, Owen KR, et al.: Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003, 52:568–572.PubMedCrossRefGoogle Scholar
  9. 9.
    Love-Gregory L, Wasson J, Lin J, et al.: E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of type II diabetes in Caucasians as the PPARgamma Pro12Ala variant. Diabetologia 2003, 46:136–137.PubMedGoogle Scholar
  10. 10.
    Nielsen EM, Hansen L, Carstensen B, et al.: The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003, 52:573–577.PubMedCrossRefGoogle Scholar
  11. 11.
    Florez JC, Burtt N, de Bakker PI, et al.: Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 2004, 53:1360–1368.PubMedCrossRefGoogle Scholar
  12. 12.
    Shih DQ, Stoffel M: Molecular etiologies of MODY and other early-onset forms of diabetes. Curr Diab Rep 2002, 2:125–134. A recent paper describing genes in which variants are known to cause MODY, and describing how these genes form an integrated transcriptional network important in many metabolic pathways. Also described are other early-onset maternally inherited and recessive forms of T2DM.PubMedGoogle Scholar
  13. 13.
    Zouali H, Hani EH, Philippi A, et al.: A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 1997, 6:1401–1408.PubMedCrossRefGoogle Scholar
  14. 14.
    Permutt MA, Wasson JC, Suarez BK, et al.: A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 2001, 50:681–685.PubMedCrossRefGoogle Scholar
  15. 15.
    Love-Gregory LD, Wasson J, Ma J, et al.: A common polymorphism in the upstream promoter region of the Hepatocyte Nuclear Factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 2004, 53:1134–1140. Description of the identification of variants in and around HNF4A that are associated with T2DM in an Ashkenazi Jewish sample from Israel using a positional-candidate and haplotype-map-based strategy. These variants explain a substantial portion of the 20q linkage signal in these families.PubMedCrossRefGoogle Scholar
  16. 16.
    Iwasaki N, Cox NJ, Wang YQ, et al.: Mapping genes influencing type 2 diabetes risk and BMI in Japanese subjects. Diabetes 2003, 52:209–213.PubMedCrossRefGoogle Scholar
  17. 17.
    Mori Y, Otabe S, Dina C, et al.: Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002, 51:1247–1255.PubMedCrossRefGoogle Scholar
  18. 18.
    Bowden DW, Sale M, Howard TD, et al.: Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 1997, 46:882–886.PubMedCrossRefGoogle Scholar
  19. 19.
    Vionnet N, Hani El H, Dupont S, et al.: Genome-wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67:1470–1480.PubMedCrossRefGoogle Scholar
  20. 20.
    Ghosh S, Watanabe RM, Valle TT, et al.: The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000, 67:1174–1185.PubMedGoogle Scholar
  21. 21.
    Silander K, Scott LJ, Valle TT, et al.: A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes 2004, 53:821–829.PubMedCrossRefGoogle Scholar
  22. 22.
    Ji L, Malecki M, Warram JH, et al.: New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997, 46:876–881.PubMedCrossRefGoogle Scholar
  23. 23.
    Klupa T, Malecki MT, Pezzolesi M, et al.: Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes 2000, 49:2212–2216.PubMedCrossRefGoogle Scholar
  24. 24.
    Luo TH, Zhao Y, Li G, et al.: A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 2001, 44:501–506.PubMedCrossRefGoogle Scholar
  25. 25.
    Rotimi CN, Chen G, Adeyemo AA, et al.: A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Diabetes 2004, 53:838–841.PubMedCrossRefGoogle Scholar
  26. 26.
    Lee JH, Reed DR, Li WD, et al.: Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 1999, 64:196–209.PubMedCrossRefGoogle Scholar
  27. 27.
    Hunt SC, Abkevich V, Hensel CH, et al.: Linkage of body mass index to chromosome 20 in Utah pedigrees. Hum Genet 2001, 109:279–285.PubMedCrossRefGoogle Scholar
  28. 28.
    Lembertas AV, Perusse L, Chagnon YC, et al.: Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 1997, 100:1240–1247.PubMedGoogle Scholar
  29. 29.
    Duggirala R, Blangero J, Almasy L, et al.: A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesityrelated phenotypes in nondiabetic Mexican Americans. Am J Hum Genet 2001, 68:1149–1164.PubMedCrossRefGoogle Scholar
  30. 30.
    Norman RA, Tataranni PA, Pratley R, et al.: Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet 1998, 62:659–668.PubMedCrossRefGoogle Scholar
  31. 31.
    Soro A, Pajukanta P, Lilja HE, et al.: Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am J Hum Genet 2002, 70:1333–1340.PubMedCrossRefGoogle Scholar
  32. 32.
    LinJP: Genome-wide scan on plasma triglyceride and high density lipoprotein cholesterol levels, accounting for the effects of correlated quantitative phenotypes. BMC Genet 2003, 4(suppl 1):S47.PubMedCrossRefGoogle Scholar
  33. 33.
    Schadt EE, Monks SA, Drake TA, et al.: Genetics of gene expression surveyed in maize, mouse and man. Nature 2003, 422:297–302.PubMedCrossRefGoogle Scholar
  34. 34.
    Fossey SC, Mychaleckyj JC, Pendleton JK, et al.: A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20. Genomics 2001, 76:45–57.PubMedCrossRefGoogle Scholar
  35. 35.
    Permutt MA, Wasson J, Love-Gregory L, et al.: Searching for type 2 diabetes genes on chromosome 20. Diabetes 2002, 51(suppl 3):S308-S315.PubMedCrossRefGoogle Scholar
  36. 36.
    Silander K, Mohlke KL, Scott LJ, et al.: Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 2004, 53:1141–1149. Report of the identification of variants in and around HNF4A that are associated with T2DM in a large Finnish sample using a pool-based screening strategy. These variants explain a substantial portion of the evidence for 20q linkage in these families.PubMedCrossRefGoogle Scholar
  37. 37.
    Barroso I, Luan J, Middelberg RP, et al.: Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 2003, 1:E20. Description of a T2DM candidate gene study of 152 SNPs in 71 genes based on 2134 Caucasians from the United Kingdom, emphasizing genes that influence pancreatic β-cell function and insulin action. The authors identify a two-SNP HNF4A haplotype that is protective against T2DM and associated with increased insulin secretion.PubMedCrossRefGoogle Scholar
  38. 38.
    Hansen SK, Parrizas M, Jensen ML, et al.: Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. J Clin Invest 2002, 110:827–833.PubMedCrossRefGoogle Scholar
  39. 39.
    Boj SF, Parrizas M, Maestro MA, Ferrer J: A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A 2001, 98:14481–14486.PubMedCrossRefGoogle Scholar
  40. 40.
    Thomas H, Jaschkowitz K, Bulman M, et al.: A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 2001, 10:2089–2097.PubMedCrossRefGoogle Scholar
  41. 41.
    Odom DT, Zizlsperger N, Gordon DB, et al.: Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303:1378–1381. The authors use chromatin immunoprecipitation and promoter microarrays to identify genes occupied by HNF1A, HNF4A, and HNF6 in human liver and pancreatic islets, and identify tissue-specific regulatory circuits formed by these and other transcription factors. They suggest that these genes function as master regulators of hepatocyte and islet transcription and how misregulation of HNF4A can contribute to risk of T2DM.PubMedCrossRefGoogle Scholar
  42. 42.
    The International HapMap Consortium: The International HapMap Project. Nature 2003, 426:789–796.CrossRefGoogle Scholar
  43. 43.
    Mohlke KL, Erdos MR, Scott LJ, et al.: High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proc Natl Acad Sci U S A 2002, 99:16928–16933.PubMedCrossRefGoogle Scholar
  44. 44.
    Weedon MN, Owen KR, Shields B, et al.: Common variants of the HNF4alpha P2 promoter are associated with type 2 diabetes in the UK population. Diabetes 2004, 53:3002–3006. Follow-up study of Silander et al. [36] and Love-Gregory et al. [15] that confirms the association between HNF4A promoter variants and T2DM in a study of 5256 U.K. Caucasian subjects, but suggests a weaker HNF4A effect on T2DM risk.PubMedCrossRefGoogle Scholar
  45. 45.
    Damcott CM, Hoppman N, Ott SH, et al.: Polymorphisms in both promoters of hepatocyte nuclear factor 4-alpha are associated with type 2 diabetes in the Amish. Diabetes 2004, 53:3337–3341. Follow-up study of Silander et al. [36] and Love-Gregory et al. [15] that supports the association between HNF4A promoter variants and T2DM in subjects from the Amish Family Diabetes Study.PubMedCrossRefGoogle Scholar
  46. 46.
    Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K: A comprehensive review of genetic association studies. Genet Med 2002, 4:45–61.PubMedGoogle Scholar
  47. 47.
    Lohmueller KE, Pearce CL, Pike M, et al.: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177–182.PubMedCrossRefGoogle Scholar
  48. 48.
    Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat Genet 2001, 29:306–309.PubMedCrossRefGoogle Scholar
  49. 49.
    Fingerlin TE, Boehnke M, Abecasis GR: Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information. Am J Hum Genet 2004, 74:432–443.PubMedCrossRefGoogle Scholar
  50. 50.
    Frayling TM, McCarthy MI, Walker M, et al.: No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians. J Clin Endocrinol Metab 2000, 85:853–857.PubMedCrossRefGoogle Scholar
  51. 51.
    Wiltshire S, Hattersley AT, Hitman GA, et al.: A genome-wide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 2001, 69:553–569.PubMedCrossRefGoogle Scholar
  52. 52.
    Hsueh WC, St Jean PL, Mitchell BD, et al.: Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes 2003, 52:550–557.PubMedCrossRefGoogle Scholar
  53. 53.
    Yamagata K: Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY). Endocr J 2003, 50:491–499.PubMedCrossRefGoogle Scholar
  54. 54.
    Shih DQ, Dansky HM, Fleisher M, et al.: Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 2000, 49:832–837.PubMedCrossRefGoogle Scholar
  55. 55.
    Furuta H, Iwasaki N, Oda N, et al.: Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 1997, 46:1652–1657.PubMedCrossRefGoogle Scholar
  56. 56.
    Moller AM, Urhammer SA, Dalgaard LT, et al.: Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4alpha in Caucasians with maturity onset NIDDM. Diabetologia 1997, 40:980–983.PubMedCrossRefGoogle Scholar
  57. 57.
    Hani EH, Suaud L, Boutin P, et al.: A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulindependent diabetes mellitus. J Clin Invest 1998, 101:521–526.PubMedCrossRefGoogle Scholar
  58. 58.
    Malecki MT, Antonellis A, Casey P, et al.: Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for lateonset NIDDM linked with chromosome 20q. Diabetes 1998, 47:970–972.PubMedCrossRefGoogle Scholar
  59. 59.
    Ghosh S, Watanabe RM, Hauser ER, et al.: Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A 1999, 96:2198–2203.PubMedCrossRefGoogle Scholar
  60. 60.
    Lausen J, Thomas H, Lemm I, et al.: Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 2000, 28:430–437.PubMedCrossRefGoogle Scholar
  61. 61.
    Price JA, Fossey SC, Sale MM, et al.: Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients. Diabetologia 2000, 43:364–372.PubMedCrossRefGoogle Scholar
  62. 62.
    Mitchell SM, Vaxillaire M, Thomas H, et al.: Rare variants identified in the HNF 4 alpha beta-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset type II diabetes. Diabetologia 2002, 45:1344–1348.PubMedCrossRefGoogle Scholar
  63. 63.
    Zhu Q, Yamagata K, Miura A, et al.: T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetologia 2003, 46:567–573.PubMedGoogle Scholar
  64. 64.
    Ek J, Rose CS, Jensen DP, et al.: Large-scale epidemiological and functional studies of the Thr130Ile and Val255Met polymorphisms in the Hepatocyte Nuclear Factor-4alpha gene in relation to type 2 diabetes. Am J Hum Genet 2004, 75(suppl):398.CrossRefGoogle Scholar
  65. 65.
    Navas MA, Munoz-Elias EJ, Kim J, et al.: Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes 1999, 48:1459–1465.PubMedCrossRefGoogle Scholar
  66. 66.
    Briancon N, Bailly A, Clotman F, et al.: Expression of the alpha7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4alpha1 in the liver. J Biol Chem 2004, 279:33398–33408.PubMedCrossRefGoogle Scholar
  67. 67.
    Olivier M, Hsiung CA, Chuang LM, et al.: Single nucleotide polymorphisms in protein tyrosine phosphatase 1 beta (PTPN1) are associated with essential hypertension and obesity. Hum Mol Genet 2004, 13:1885–1892.PubMedCrossRefGoogle Scholar
  68. 68.
    Bento JL, Palmer ND, Mychaleckyj JC, et al.: Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 2004, 53:3007–3012.PubMedCrossRefGoogle Scholar
  69. 69.
    Palmer ND, Bento JL, Mychaleckyj JC, et al.: Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2004, 53:3013–3019.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • Karen L. Mohlke
    • 1
  • Michael Boehnke
  1. 1.Department of GeneticsUniversity of North CarolinaChapel HillUSA

Personalised recommendations